Boundless Bio, Inc. (BOLD) stock

BOLDNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30

$2.46+0.00 (0.00%)

Close on Nov 12, 2026Market cap $55.96MP/E –Yield –

Boundless Bio price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Boundless Bio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?